MSF calls for urgent action on vaccines to save lives

29 October 2013
msf-big

Humanitarian medical organization Medecins Sans Frontieres (MSF) is calling for four key policy changes to reduce the number of children missing out on vaccinations globally (22.6 million in 2012).

It called for action as the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization) faces its progress review in Stockholm, Sweden. GAVI is a public-private global health partnership committed to saving children’s lives and protecting people’s health by increasing access to immunization in poor countries

Kate Elder, vaccines policy advisor at MSF’s Access Campaign, said: “We think GAVI should be commended for many of its accomplishments over the last decade, but we also think it’s very important for GAVI to take a close and critical look at what it can improve going forward. We believe an ambitious, inclusive GAVI that will fight hard to shape markets, products and prices, is essential in helping the world meet its immunisation targets and preventing disease in the most vulnerable.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical